Truxil

Truxil30 mg+10 mg

Tablet

Almitrine Bismesylate + Raubasine

Square Pharmaceuticals PLC.

Product Code : 17457
MRP 11.00
10% Off
Best PriceTk
/
1
Section

Medicine overview

Indications of Truxil 30 mg+10 mg

This tablet is indicated for- Reduction of neurological damage & accelerates recovery after cerebral stroke Minor age-related neurological disorders Some visual disorders related to the circulation Some disorders of the inner ear related to circulation (hearing loss, dizziness, buzzing sounds in the ear).

Theropeutic Class

Cerebral vasodilator & Neurosensory oxygenator drugs

Pharmacology

Almitrine Bismesylate & Raubasine combines raubasine, a vasodilator; and almitrine, a respiratory stimulant. Raubasine has a adrenolytic activity which is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa02); almitrine causes an increase in the Pa02 and an increase in the oxygen saturation in arterial blood (Sa02), without modifying ventilatory parameters.

Dosage & Administration of Truxil 30 mg+10 mg

Usually 1-2 tablets daily (with a several hours interval).

Dosage of Truxil 30 mg+10 mg

1 tablet once or twice daily (taken separately, several hours apart), without exceeding 2 tablets per day. Or, as directed by the registered physicians.

Interaction of Truxil 30 mg+10 mg

Do not associate with MAO-l (monoamine oxidase inhibitor), Not to be used concurrently with other almitrine-containing preparations.

Contraindications

This tablet is contraindicated in patients with hypersensitivity to any of the ingredients of it or severe hepatic impairment.

Side Effects of Truxil 30 mg+10 mg

Weight loss, nausea, sensations of heaviness or burning in the stomach, gastrointestinal disorders, diarrhoea or constipation, insomnia, drowsiness, agitation, anxiety, dizziness, palpitations.

Pregnancy & Lactation

Consulting with physicians is required to take this medicine.

Precautions & Warnings

Due to the presence of lactose, this drug should not be used in the case of galactosemia, of glucose and galactose malabsorption syndrome or of lactose deficiency (rare metabolic diseases). Do not exceed the recommended dose.

Overdose Effects of Truxil 30 mg+10 mg

Signs include tachycardia, arterial hypotension, polypnoea and respiratory alkalosis.

Storage Conditions

Store at a cool and dry place, protected from light and moisture. Keep out of reach of children.

Drug Classes

Cerebral vasodilator & Neurosensory oxygenator drugs

Mode Of Action

Almitrine Bismesylate & Raubasine combines raubasine, a vasodilator; and almitrine, a respiratory stimulant. Raubasine has a adrenolytic activity which is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa02); almitrine causes an increase in the Pa02 and an increase in the oxygen saturation in arterial blood (Sa02), without modifying ventilatory parameters.

Pregnancy

It is not recommended in pregnancy. It should be used with caution only when the expected benefit to the mother is greater than the possible risk to the fetus.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.